Jeffrey Nadrich

http://www.personalinjurylawcal.com/actos-side-effects.php

Nadrich & Cohen is investigating Actos (Pioglitazone) victims in all 50 states who've been diagnosed with Bladder Cancer. Sadly, this diabetes drug has been linked to Bladder Cancer. On July 11, 2011, the French drug regulatory agency suspended the sale of Actos in France because of the bladder cancer risk . This action was taken after a large study of over 150,000 diabetic patients which compared individuals who used Actos (including the generic version) with those who did not. The study concluded that using a high dose of Actos over a period of one year or more greatly increases the risk of bladder cancer.